Accretion Pharmaceuticals Limited
Share Price Target & Analysis
NSE:ACCPL
VWAP
Open
Close
High
Low
52 Week High
1.90 (0.95%)
ACCPL
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Standard
Quality
Silver
Valuation
#Analysis
NSE: ACCPL Share Price Financial Analysis & Valuation
Accretion Pharmaceuticals Limited (ACCPL) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals & Drugs vertical.
It is one of Micro Cap company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Accretion Pharmaceuticals Limited is listed on NSE with Exchange ID - INE0T8T01010 and trading code is NSE:ACCPL with short name Accretion Pharm.
In the past 1 year, Accretion Pharmaceuticals Limited has declared an equity dividend of Rs 0 per share. At the current share price of ACCPL at Rs 201.90, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:ACCPL, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine ACCPL underlying value and future prospects. All of this data is available in ACCPL financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:ACCPL, it is clearly understood that ACCPL is Standard performer in terms of earnings and profit margins with an EPS of 10.16. NSE:ACCPL book value per share as of today is 49.22. The current price to book ratio for ACCPL as of Sep 07, 2026 is 4.1.
Valuation of the Stock: The current valuation of ACCPL stock is like Silver which means currently the stock is at Premium. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of ACCPL whether to BUY this stock at current valuation. The delivery percentage of ACCPL is 13200% is very crucial parameter which shows that 13200% investors are anticipating that the price of ACCPL share should go up with VWAP at 203.45.
Now, the main question is whether to BUY or SELL, NSE:ACCPL at current valuation.
As per latest Analysis No. #30:-
⇑ STRONG BUY ACCPL if All Greens
⇗ BUY ACCPL (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD ACCPL (With Stop Loss) if only 1 Green
⇘ SELL ACCPL if NO Green Indicator
NSE: ACCPL Share Price Today (Sep 07, 2026)
(Accretion Pharmaceuticals Limited Daily Analysis on the basis of ACCPL Intraday Graph & Trend)
Accretion Pharmaceuticals Limited share price moved Up by 0.95% from its previous close of Rs 200. ACCPL stock last traded price is 201.90. ACCPL share price trend is Up with a total of 3600 stocks traded till now. It has touched an intraday high of Rs 205 and an intraday low of Rs 201.9. The ACCPL trading at 201.90, Up by Rs. 1.90, or 0.95 percent which suggests that most of the Traders are anticipating that the price of ACCPL share should go Up.
NSE: ACCPL Share Price Tomorrow Prediction
(Accretion Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of ACCPL)
Accretion Pharmaceuticals Limited share price moved Up by 0.95%. ACCPL share price short term trend is Up. It suggests that ACCPL Share Price for Tomorrow remains the same with VWAP at 203.45 will be treated as stop loss for intraday traders. Accretion Pharmaceuticals Limited Long term investors can follow the ACCPL long term trend as mentiond in future forecast table.
NSE Code |
NSE: ACCPL |
ACCPL Share Price Today |
201.90 |
ACCPL Share Price Target Prediction for 2026 ^ |
129.5 - 215.8 |
ACCPL Share Price Target Prediction for 2027*^ |
215.8 - 229.9 |
ACCPL Share Price Target Prediction for 2028*^ |
229.9 - 246 |
ACCPL Share Price Target Prediction for 2029*^ |
258 |
ACCPL Share Price Target Prediction for 2030*^ |
266 |
ACCPL Share Price Target Prediction for 2035*^ |
290 |
| ACCPL Current Book Value |
49 |
*Accretion Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^ACCPL share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
ACCPL Technical Analysis (In Process... .. .)
Please wait for a while and refresh the page to check again.
Most popular Questions & Answers about ACCPL (/ FAQ ACCPL)
Accretion Pharmaceuticals Limited stock last traded price is 201.90. ACCPL share price moved Up by 0.95% from its previous close of Rs 200.
Accretion Pharmaceuticals Limited share price trend is Up with a total of 3600 stocks traded till now. It has touched an intraday high of Rs 216.847 and an intraday low of Rs 201.9. The ACCPL trading at 201.90, Up by Rs. 1.90, or 0.95 percent which suggests that most of the Traders are anticipating that the price of ACCPL share should go Up and the Stop Loss will be around 203.45.
The market cap of Accretion Pharmaceuticals Limited is ₹0 (in Cr) as of Sep 06, 2026.
The current price to earning ratio for Accretion Pharmaceuticals Limited as of Sep 06, 2026 is 23.21.
The current price to book ratio for Accretion Pharmaceuticals Limited as of Sep 06, 2026 is 4.1.
The highest price of Accretion Pharmaceuticals Limited stock is ₹214.7 in the last 52-week.
The lowest price of Accretion Pharmaceuticals Limited stock is ₹53.8 in the last 52-week.
Accretion Pharmaceuticals Limited share trading at ₹201.90, Up by Rs. 1.90, or 0.95 percent which suggests that most of the traders are anticipating that the price of ACCPL share should go Up.
In 2026, Stock price target for Accretion Pharmaceuticals Limited (ACCPL) will be around ₹129.5 on downside and ₹215.8 on upside. Accretion Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Accretion Pharmaceuticals Limited (ACCPL) will be around ₹215.8 on downside and ₹229.9 on upside. Accretion Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Accretion Pharmaceuticals Limited (ACCPL) will be around ₹229.9 on downside and ₹246 on upside. Accretion Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Accretion Pharmaceuticals Limited (ACCPL) will be around ₹266 Accretion Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of ACCPL.
The price of Accretion Pharmaceuticals Limited (ACCPL) shares moved by 0.95%. The short-term trend for ACCPL share price is Up. It implies that the share price of ACCPL will stay the same tomorrow and that intraday traders should treat VWAP at 203.45 as a stop loss. Investors with a long-term outlook can track ACCPL long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of ACCPL stock is 121.8. Compared to the current market price of 201.90 INR, the ACCPL stock is Overvalued by 39.7%.
As per the fundamental analysis of Accretion Pharmaceuticals Limited (ACCPL), it is of Standard quality in terms of earnings and profit margins with an EPS of 10.16. Accretion Pharmaceuticals Limited book value per share as of today is 49.22. The current price to book ratio for ACCPL as of Sep 07, 2026 is 4.1.
NSE:ACCPL News & Other Useful Information about ACCPL Share Price
Peer Comparison of NSE: ACCPL
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals & Drugs
| Company | Price | EPS | BV |
|---|---|---|---|
| ZYDUSLIFE | 1126.20 | 40.96 | 238.63 |
| GLAND | 2974.30 | 89.58 | 677.38 |
| CADILAHC | 1126.20 | 40.96 | 238.63 |
| MADHAVBAUG | 160.50 | 10.03 | 61.48 |
| SUVENPHAR | 376.20 | 11.05 | 115.25 |
| ERIS | 1324.30 | 29.16 | 234.07 |
| PGHL | 5667.00 | 211.15 | 373.93 |
| SYMBIOTEC | 1096.40 | 4.53 | 105.01 |
| GLS | 1350.20 | 49.12 | 284.45 |
| SUPRIYA | 902.70 | 29.51 | 151.81 |
| SIGACHI | 34.21 | -1.7 | 12.62 |
| SAKAR | 1109.20 | 24.29 | 150.48 |
| ORTINLAB | 14.93 | 0 | 1.11 |
| WALPAR | 22.80 | 2.55 | 18.08 |
| JSLL | 522.00 | 21.7 | 42.89 |
| JFLLIFE | 10.05 | 2.27 | 12.12 |
| MANKIND | 2313.00 | 59.75 | 410.5 |
| SOTAC | 90.05 | 6.71 | 52.33 |
| REMUS | 914.90 | 23.29 | 276.4 |
| VILINBIO | 56.95 | 1.57 | 18.6 |
| SAROJA | 38.95 | 0 | 43 |
| VALIANTLAB | 108.79 | 1.44 | 60.62 |
| BLUEJET | 564.45 | 15.67 | 82.91 |
| ACCENTMIC | 618.15 | 20.63 | 114.84 |
| ZENITHDRUG | 42.50 | 5.83 | 43.69 |
| INNOVACAP | 1187.50 | 21.16 | 160.54 |
| ENTERO | 1900.30 | 8.88 | 387.5 |
| EMCURE | 1942.80 | 51.69 | 206.16 |
| MEDIORG | 26.50 | -1.83 | 21.18 |
| AKUMS | 763.30 | 10.26 | 157.14 |